Metabolomics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Metabolomics Market
1.1. Definition and Scope
1.1.1. Definition of Metabolomics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Metabolomics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Metabolomics Market By Product & Service
1.2.3. Metabolomics Market By Indication
1.2.4. Metabolomics Market By Application
1.2.5. Metabolomics Market By End-Use
1.2.6. Metabolomics Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Metabolomics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Metabolomics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Flooring & Wall Panels Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Metabolomics Market By Product & Service
5.1. Introduction
5.2. Metabolomics Market Revenue By Product & Service
5.2.1. Metabolomics Market Revenue (USD Billion) and Forecast, By Product & Service, 2020-2032
5.2.2. Metabolomics Instruments
5.2.2.1. Metabolomics Instruments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Metabolomics Bioinformatics Tools & Service
5.2.3.1. Metabolomics Bioinformatics Tools & Service Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Metabolomics Market By Indication
6.1. Introduction
6.2. Metabolomics Market Revenue By Indication
6.2.1. Metabolomics Market Revenue (USD Billion) and Forecast, By Indication, 2020-2032
6.2.2. Cancer
6.2.2.1. Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Cardiovascular Disorders
6.2.3.1. Cardiovascular Disorders Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Neurological Disorders
6.2.4.1. Neurological Disorders Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Inborn Errors of Metabolism
6.2.5.1. Inborn Errors of Metabolism Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Others
6.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Metabolomics Market By Application
7.1. Introduction
7.2. Metabolomics Market Revenue By Application
7.2.1. Metabolomics Market Revenue (USD Billion) and Forecast, By Application, 2020-2032
7.2.2. Biomarker Discovery
7.2.2.1. Biomarker Discovery Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Drug Discovery
7.2.3.1. Drug Discovery Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Toxicology Testing
7.2.4.1. Toxicology Testing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.5. Nutrigenomics
7.2.5.1. Nutrigenomics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.6. Functional Genomics
7.2.6.1. Functional Genomics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.7. Personalized Medicine
7.2.7.1. Personalized Medicine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.8. Others
7.2.8.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Metabolomics Market By End-Use
8.1. Introduction
8.2. Metabolomics Market Revenue By End-Use
8.2.1. Metabolomics Market Revenue (USD Billion) and Forecast, By End-Use, 2020-2032
8.2.2. Academic Research & Institutes
8.2.2.1. Academic Research & Institutes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Pharmaceutical & Biotechnology Companies
8.2.3.1. Pharmaceutical & Biotechnology Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Contract Research Organizations
8.2.4.1. Contract Research Organizations Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.5. Others
8.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Metabolomics Market By Country
9.1. North America Metabolomics Market Overview
9.2. U.S.
9.2.1. U.S. Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
9.2.2. U.S. Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.2.3. U.S. Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.2.4. U.S. Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
9.3. Canada
9.3.1. Canada Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
9.3.2. Canada Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.3.3. Canada Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.3.4. Canada Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Metabolomics Market By Country
10.1. Europe Metabolomics Market Overview
10.2. U.K.
10.2.1. U.K. Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
10.2.2. U.K. Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.2.3. U.K. Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.2.4. U.K. Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.3. Germany
10.3.1. Germany Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
10.3.2. Germany Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.3.3. Germany Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.3.4. Germany Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.4. France
10.4.1. France Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
10.4.2. France Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.4.3. France Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.4.4. France Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.5. Spain
10.5.1. Spain Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
10.5.2. Spain Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.5.3. Spain Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.5.4. Spain Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
10.6.2. Rest of Europe Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.6.3. Rest of Europe Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.6.4. Rest of Europe Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia-Pacific Metabolomics Market By Country
11.1. Asia-Pacific Metabolomics Market Overview
11.2. China
11.2.1. China Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
11.2.2. China Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.2.3. China Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.4. China Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.3. Japan
11.3.1. Japan Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
11.3.2. Japan Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.3.3. Japan Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.4. Japan Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.4. India
11.4.1. India Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
11.4.2. India Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.4.3. India Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.4.4. India Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.5. Australia
11.5.1. Australia Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
11.5.2. Australia Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.5.3. Australia Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.5.4. Australia Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.6. South Korea
11.6.1. South Korea Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
11.6.2. South Korea Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.6.3. South Korea Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.6.4. South Korea Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
11.7.2. Rest of Asia-Pacific Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.7.3. Rest of Asia-Pacific Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.7.4. Rest of Asia-Pacific Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.8. Asia-Pacific PEST Analysis
CHAPTER 12. Latin America Metabolomics Market By Country
12.1. Latin America Metabolomics Market Overview
12.2. Brazil
12.2.1. Brazil Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
12.2.2. Brazil Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.2.3. Brazil Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
12.2.4. Brazil Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.3. Mexico
12.3.1. Mexico Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
12.3.2. Mexico Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.3.3. Mexico Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
12.3.4. Mexico Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
12.4.2. Rest of Latin America Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.4.3. Rest of Latin America Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
12.4.4. Rest of Latin America Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Metabolomics Market By Country
13.1. Middle East & Africa Metabolomics Market Overview
13.2. GCC
13.2.1. GCC Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
13.2.2. GCC Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
13.2.3. GCC Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
13.2.4. GCC Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
13.3. South Africa
13.3.1. South Africa Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
13.3.2. South Africa Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
13.3.3. South Africa Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
13.3.4. South Africa Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
13.4.2. Rest of Middle East & Africa Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
13.4.3. Rest of Middle East & Africa Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
13.4.4. Rest of Middle East & Africa Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Metabolomics Market
14.1. Metabolomics Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by Product & Service, presence, market share, and R&D investment
14.2.2. New Product & Service Launches and Product & Service Enhancements
14.2.3. Mergers And Acquisition In Global Metabolomics Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Thermo Fisher Scientific Inc.
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. Thermo Fisher Scientific Inc. 2022 Metabolomics Business Regional Distribution
15.1.4. Product & Service/Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Biocrates Life Sciences AG
15.3. Human Metabolome Technologies Inc.
15.4. Metabolon Inc.
15.5. Bruker Corporation
15.6. LECO Corporation
15.7. Waters Corporation
15.8. Agilent Technologies
15.9. Bio-Rad laboratories Inc.
15.10. Shimadzu Corporation
Frequently Asked Questions
What was the market size of the global metabolomics in 2022?
The market size of metabolomics was USD 2.4 Billion in 2022.
What is the CAGR of the global metabolomics market during forecast period of 2023 to 2032?
The CAGR of metabolomics market is 13.2% during the analysis period of 2023 to 2032.
Which are the key players operating in the market?
The key players operating in the global market are include Thermo Fisher Scientific Inc., Biocrates Life Sciences AG, Human Metabolome Technologies Inc., Metabolon Inc., Bruker Corporation, LECO Corporation, Waters Corporation, Agilent Technologies, Bio-Rad laboratories Inc., Shimadzu Corporation.
Which region held the dominating position in the global metabolomics market?
North America held the dominating position in metabolomics market during the analysis period of 2023 to 2032.
Which region registered the fastest growing CAGR for the forecast period of 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for metabolomics market during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global metabolomics market?
The current trends and dynamics in the metabolomics industry include increasing demand for personalized medicine, increased funding for metabolomics research, and growing applications in drug discovery and development.
Which indication held the maximum share in 2022?
The cancer indication held the maximum share of the metabolomics market.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
